Noxopharm Ltd (nox) Logo

Noxopharm Ltd (NOX)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials
News
Announcements

NOX ASX Chart

Snapshot

Noxopharm Limited (NOX) is a clinical-stage Australian biotech company discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to improve the safety profile of a range of mRNA medicines. The company utilises in house capabilities and strategic partnerships with researchers to build a growing pipeline of new proprietary drugs based on two technology platforms - Sofra (inflammation, autoimmunity, mRNA drug enhancement, and oncology) and Chroma (oncology).

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2026 YTD
1 Year
vs Sector (1yr) +143.12%
vs ASX 200 (1yr) +104.29%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,501 of 2,337
Sector Rank 129 of 241

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies HCT / PAB / 1AI
EPS -$0.019
DPS $0.00
Book Value Per Share -$0.004

Broker Consensus

NOX is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Castle Hill NSW 2154
Website www.noxopharm.com
Registry Automic Group
Auditor William Buck Audit (VIC) Pty Ltd
Date Listed 9 Aug 2016

Upcoming Calendar (Forecasted)

Date Event
28/08/2026 Report (Prelim)
28/09/2026 Report (Annual)
12/10/2026 Report (Annual)
26/02/2027 Report (Interim)

Former Company Names

  • Noxopharm Ltd has no former company names.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

NOX directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
25/05/26 Boris Patkin Transfer 630,000 $0.06 $37,800 Off-market transfer
25/05/26 Boris Patkin Transfer 630,000 $0.06 $37,800 Off-market transfer
12/12/25 Frederick (Fred) Bart Issued 1,250,000 $1.00 $1,250,000 Issue of securities
12/12/25 Frederick (Fred) Bart Issued 250,000 $0.099 $24,750 Issue of options
15/09/23 Frederick (Fred) Bart Buy +880 $0.034 $30 On-market trade
14/09/23 Frederick (Fred) Bart Buy +253,001 $0.036 $9,108 On-market trade
30/06/23 Frederick (Fred) Bart Buy +135,281 $0.042 $5,681 On-market trade
29/06/23 Frederick (Fred) Bart Transfer 3,080,189 $0.055 $170,950 Off-market transfer
29/06/23 Frederick (Fred) Bart Transfer 3,080,189 $0.055 $170,950 Off-market transfer
09/05/23 Frederick (Fred) Bart Buy +500,000 $0.042 $21,000 On-market trade
04/05/23 Frederick (Fred) Bart Buy +1,000,000 $0.05 $50,000 On-market trade
15/12/22 Frederick (Fred) Bart Expiry 3,000,000 $0.145 $435,000 Options expired
01/12/21 Graham Kelly Expiry 37,037 $0.44 $16,296 Options expired
31/05/21 Boris Patkin Issued 250,000 $0.735 $183,750 Director remuneration
31/05/21 Frederick (Fred) Bart Issued 3,080,189 $0.513 $1,580,137 Issue of securities
29/04/21 Boris Patkin Cancelled 250,000 $0.60 $150,000 Cancellation of securities
26/02/21 Peter Marks Buy +200,000 $0.30 $60,000 Exercise of options
26/02/21 Peter Marks Exercise 200,000 $0.30 $60,000 Exercise of options
26/02/21 Graham Kelly Expiry 4,075,000 $0.685 $2,791,375 Options expired
26/02/21 Graham Kelly Buy +8,000,000 $0.30 $2,400,000 Exercise of options
26/02/21 Graham Kelly Exercise 8,000,000 $0.30 $2,400,000 Exercise of options
23/02/21 Graham Kelly Sell +8,840,000 $0.652 ($5,760,000) Off-market trade
15/12/20 Frederick (Fred) Bart Issued 3,000,000 $0.46 $1,380,000 Director remuneration
15/12/20 Boris Patkin Issued 250,000 $0.46 $115,000 Director remuneration
27/11/20 Peter Marks Expiry 500,000 $0.635 $317,500 Options expired
18/11/20 Graham Kelly Issued 62,500 $0.69 $43,125 Issue of securities
24/07/20 Frederick (Fred) Bart Transfer 1,018,773 $0.191 $195,051 On-market transfer
24/07/20 Frederick (Fred) Bart Transfer 3,056,318 $0.344 $1,051,211 On-market transfer
23/06/20 Frederick (Fred) Bart Transfer 846,154 $0.185 $156,538 Off-market transfer
23/06/20 Frederick (Fred) Bart Transfer 2,538,462 $0.13 $330,000 Off-market transfer
18/06/20 Graham Kelly Issued 1,820,513 $0.19 $345,897 Rights issue
18/06/20 Graham Kelly Issued 5,461,538 $0.13 $709,999 Rights issue
18/06/20 Peter Marks Issued 66,667 $0.19 $12,666 Rights issue
18/06/20 Peter Marks Issued 200,000 $0.13 $26,000 Rights issue
18/06/20 Frederick (Fred) Bart Issued 1,018,773 $0.19 $193,566 Rights issue
18/06/20 Frederick (Fred) Bart Issued 3,056,318 $0.13 $397,321 Rights issue
18/06/20 Boris Patkin Issued 60,000 $0.19 $11,400 Rights issue
18/06/20 Boris Patkin Issued 180,000 $0.13 $23,400 Rights issue
10/09/19 Graham Kelly Buy +53,263 $0.358 $19,063 On-market trade
06/09/19 Graham Kelly Buy +11,737 $0.362 $4,250 On-market trade
13/02/19 Graham Kelly Buy +65,553 $0.416 $27,282 On-market trade
21/12/18 Graham Kelly Issued 62,500 $0.46 $28,750 Issue of options
28/11/17 Peter Marks Issued 500,000 $0.84 $420,000 Issue of options
28/11/17 Ian Dixon Issued 500,000 $0.84 $420,000 Issue of options
19/12/16 Graham Kelly Buy +152,653 $0.538 $82,127 On-market trade
19/12/16 Graham Kelly Buy +6,877,568 $0.475 $3,266,845 Conversion of securities
19/12/16 Graham Kelly Exercise 6,877,568 $0.475 $3,266,845 Conversion of securities
19/12/16 Ian Dixon Buy +366,246 $0.475 $173,967 As advised by the company
18/08/16 Graham Kelly Buy +35,000 $0.15 $5,250 On-market trade
Show All

Director Interests

The current holdings of NOX directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Boris Patkin 25/05/2026 0 630,000 0 N/A
Gisela Mautner 14/04/2026 0 N/A 2,000,000 N/A
Frederick (Fred) Bart 12/12/2025 7,507,813 0 250,000 1,250,000
Peter Marks 30/06/2025 N/A 900,000 N/A N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Sep 15, 2025.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Milligene Pty Ltd (The Ge and Pr Kelly Family A/C) 34,249,106 11.72%
Mrs Eleanore Goodridge 13,050,000 4.47%
Citicorp Nominees Pty Ltd 10,992,174 3.76%
Link Traders (Aust) Pty Ltd 10,586,522 3.62%
Mr Fred Bart 7,507,813 2.57%
Rgt Capital Fund No 5 (Noxo) Pty Ltd 6,500,333 2.22%
Jamber Investments Pty Ltd (The Amber Schwarz Fam A/C) 4,252,761 1.46%
Rhlc Pty Limited (Rhlc S/F A/C) 3,000,000 1.03%
Mr Lizhong Yu 2,918,000 1.00%
Lawsam Pty Ltd (Gelski Family No 2 A/C) 2,686,376 0.92%
Mr Robert Thomas Lin 2,500,000 0.86%
Ogen Nominees Pty Ltd 2,200,000 0.75%
Mr Michael Shabat & Ms Meital Hana Shabat (M&M Shabat Super Fund A/C) 2,000,000 0.68%
Citicorp Nominees Pty Limited (120296 Infitude A/C) 1,948,438 0.67%
Mrs Sophie Ethel Gelski 1,942,424 0.66%
Helium Management Pty Ltd (Helium S/F A/C) 1,751,246 0.60%
Berne No 132 Nominess Pty Ltd (331898 A/C) 1,660,357 0.57%
Halcommunications Power Incorporated (Aust) Pty Ltd 1,600,000 0.55%
Mr Clarke James Roycroft & Mrs Judith Ann Roycroft (C J Roycroft Family A/C) 1,555,000 0.53%
Mr James John Bart 1,525,755 0.52%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 372 817 529 1,117 392 3,227

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Milligene Pty Ltd 15/09/2025 34,249,106 11.72

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2025 $0.054 30 June
2024 $0.066 28 June
2023 $0.043 30 June
2022 $0.195 30 June
2021 $0.645 30 June
2020 $0.165 30 June
2019 $0.475 28 June
2018 $0.61 29 June
2017 $0.365 30 June
NOX Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.